PNB Vesper Life's chief executive PN Balaram is upbeat the company's
experimental drug PNB-001 will be effective in treating symptoms of
Covid-19. The Kochi-based pharma company is set to begin clinical
trials on patients suffering from the disease next week.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/kochi-based-company-to-start-phase-2b-trials-of-covid-drug-next-week/articleshow/78181751.cms
No comments:
Post a Comment